Merbecovirus S2 subunit vaccines elicit cross reactive antibodies and provide partial protection against MERS coronavirus
Abstract Since the outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV), a virus that has caused a high case fatality rate of 36%, other merbecoviruses have been reported to also be capable of infecting human cells. Given the threat of Merbecovirus spillover to humans, we developed vi...
Saved in:
| Main Authors: | Peter J. Halfmann, Jeong Soo Lee, Augustine Duffy, Bingcheng Huang, Jie E. Yang, Elizabeth R. Wright, Yoshihiro Kawaoka, Ravi S. Kane |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Viruses |
| Online Access: | https://doi.org/10.1038/s44298-025-00142-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses
by: Lin Pan, et al.
Published: (2025-07-01) -
Designing Sandwich ELISA with Broadly Reactive Anti-Nucleocapsid Monoclonal Antibodies to Detect Bat-Borne Merbecoviruses
by: Kong Yen Liew, et al.
Published: (2025-06-01) -
Establishment of a Sandwich ELISA for Detection of Pan-Merbecoviruses
by: Kaixin Li, et al.
Published: (2025-06-01) -
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant
by: Peter J. Halfmann, et al.
Published: (2025-03-01) -
Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses
by: Siyuan Sun, et al.
Published: (2025-03-01)